Sciatica PRO+ Official Website › Ingredients
IngredientsWhat Is in Sciatica PRO+? The Ingredients
Sciatica PRO+ contains ten ingredients, and the bottle prints a figure for each.
Alpha lipoic acid leads at 400 mg, then benfotiamine 150 mg and acetyl L-carnitine 50 mg, three botanical powders at 25 mg each, and four vitamins at daily-requirement levels.
Next, view the full panel.
Each row below carries what it is and what the published work on it used.
What are the ten Sciatica PRO+ ingredients?
The whole list in one table, before the detail on any row.
| Row on the panel | Per 2-capsule serving | What it is |
|---|---|---|
| Vitamin D3 | 20 mcg (800 IU) | Fat-soluble, at its full daily value |
| Vitamin B6 | 1.7 mg | A coenzyme in neurotransmitter chemistry |
| Folate | 383 mcg DFE | Folate equivalents, supplied as folic acid |
| Vitamin B12 | 2 mcg | Methylcobalamin, the form that maintains myelin |
| Alpha lipoic acid | 400 mg | The largest amount and the best-researched row |
| Benfotiamine | 150 mg | A fat-soluble relative of vitamin B1 |
| Acetyl L-carnitine | 50 mg | An acetylated carnitine, in a token amount |
| Ashwagandha root powder | 25 mg | Raw powder, not a standardised extract |
| Broccoli leaf powder | 25 mg | A whole-food powder; sulforaphane is the interest |
| Turmeric root powder | 25 mg | Culinary spice, about 3 per cent curcumin |
Serving size two capsules, 30 servings a bottle.
Vitamins with an established Daily Value come first, then the six rows without one. Two of those carry nearly all the weight: 400 mg of alpha lipoic acid and 150 mg of benfotiamine come to roughly nine-tenths of the active material in a serving, while the three botanical powders contribute 75 mg between them.
Each card below gives what the compound is, what the published work used, and where the printed amount lands against that. The arithmetic is gathered in the dosage section.
Every Sciatica PRO+ ingredient, and the amount its research used
Ten cards, ordered by the weight each one contributes to a serving.
Alpha Lipoic Acid
400 mgA short fatty acid your cells make in small quantities and use inside the mitochondrion. Swallowed, it also behaves as an antioxidant in watery and fatty tissue alike, which is the property that carried it into nerve research. The oral programme converged on 600 mg a day: ALADIN III ran seven months at that amount, SYDNEY 2 weighed 600 against 1,200 and 1,800 mg and found the larger amounts bought nausea, and NATHAN 1 followed people for four years. At 400 mg this row comes nearest to its own literature, and putting the biggest number behind the best evidence was the right call.
Benfotiamine
150 mgA synthetic, fat-soluble cousin of vitamin B1 that crosses cell membranes more readily than thiamine salts. It raises transketolase activity, diverting sugar intermediates away from the pathways that damage small vessels and nerves when glucose runs high. BENDIP randomised 300 mg and 600 mg a day for six weeks, with the clearer signal in the larger arm, and the BEDIP pilot used 400 mg for three weeks. This label supplies 150 mg, half the smallest amount either study used. A 2026 critical review covers both this compound and alpha lipoic acid.
Acetyl L-Carnitine
50 mgCarnitine ferries fatty acids into the mitochondrion; the acetylated form crosses into nervous tissue more freely. The nerve work is entirely at gram scale. Two pooled 52-week randomised trials gave 1,500 mg or 3,000 mg a day, and pain scores improved in the 3,000 mg arm alone. A later meta-analysis worked in the same range, and Cochrane judged the evidence uncertain even there. Fifty milligrams is a sixtieth of the higher arm, an amount no study has examined.
Ashwagandha Powder
Withania somnifera, root25 mgAn Ayurvedan root, milled and dried. Two gaps separate this row from the studies people picture. The first is the unit: trials use standardised extracts, typically 300 to 600 mg a day, and an extract concentrates withanolides that vary widely between plant part and preparation. The second is the subject: that work measures stress, anxiety and sleep, never nerve function. Two cautions belong on the record even at 25 mg, since 600 mg of root extract moved thyroid hormone levels over eight weeks and a case series documents liver injury.
Broccoli Powder
Brassica oleracea, leaf25 mgDried leaf, milled. The compound anyone means here is sulforaphane, which is not sitting in the plant ready to use: an enzyme releases it from glucoraphanin, and that enzyme is readily destroyed by heat. The nerve evidence is a rat study, and human work has used concentrated sprout extract for metabolic endpoints instead, where the largest recent trial missed its primary endpoint.
Turmeric Powder
Curcuma longa, root25 mgThe spice itself rather than an extract, and culinary turmeric holds little curcumin: an assay of 28 commercial spice products averaged 3.14 per cent curcuminoids by weight, turning 25 mg of powder into roughly 0.8 mg. Trials use 500 to 2,000 mg of standardised curcumin, usually with piperine, because plain curcumin barely reaches the bloodstream. The single trial in diabetic nerve symptoms reached for a nano-formulated curcumin rather than the spice.
Vitamin D3
as cholecalciferol20 mcg (100% DV)The form skin makes under sunlight, and the form that raises blood levels most reliably by mouth. Twenty micrograms is 800 international units, an ordinary daily intake as MedlinePlus describes it. The nerve link is indirect: pooled observational data find low vitamin D more often in people with nerve damage, which is an association rather than a direction of travel. A 2025 meta-analysis found four supplementation trials in painful neuropathy, 320 participants in all, and declined to recommend routine use.
Vitamin B12
as methylcobalamin2 mcg (83% DV)No row here has a firmer nutritional connection to nerves. B12 maintains myelin, the sheath insulating a nerve fibre, and a true shortfall brings numbness, pins and needles and unsteadiness that the clinical literature and a BMJ review describe as reversible when caught early. Risk concentrates after fifty, in vegans, and in long-term metformin users, whom a 2026 scoping review found are often unmonitored. Two micrograms meets the requirement MedlinePlus sets out.
Folate
383 mcg DFE, as 230 mcg folic acid96% DVTwo numbers because two units are in play: 230 mcg of folic acid is absorbed more efficiently than food folate and therefore counts as 383 micrograms of dietary folate equivalents. That is an everyday amount, well beneath the 1,000 mcg daily ceiling and in line with MedlinePlus. One interaction matters because the same bottle carries B12: folic acid can normalise the blood count that a B12 shortfall disturbs, leaving the nerve damage underneath to go unnoticed.
Vitamin B6
as pyridoxine hydrochloride1.7 mg (100% DV)A coenzyme in more than a hundred reactions, several of them in building neurotransmitters, and a vitamin with an unusual risk curve. Too little causes neuropathy; so does far too much, as a 1983 case series of pyridoxine abuse established. Between those poles, a 2023 systematic review found no trial of B6 alone in peripheral neuropathy. The 1.7 mg here is the adult requirement; what deserves attention is a cupboard holding three products that each contain some.
How the Sciatica PRO+ ingredients divide into three jobs
Ten rows, three ideas, and they are not equally supported.
Metabolic support for nerve tissue
Alpha lipoic acid and benfotiamine, 550 mg between them. Both came out of research into nerve damage driven by high blood sugar, with a mechanism worked out before the trials rather than after. This is where the phrase about clinically studied ingredients has most to stand on.
Meeting an ordinary daily requirement
D3, B6, folate and B12. Nothing here is a therapeutic amount. Their job is to close a gap in someone who has one, which is a real job in a population where B12 shortfalls go undetected for years.
Antioxidant and adaptogen interest
Acetyl L-carnitine, ashwagandha, broccoli and turmeric, 125 mg for the four. Each has a literature; none of those literatures ran at anything close to these amounts, and two were not about nerves at all.
Split this way the formula is easier to judge. The first group is where the weight and the evidence both sit, the second is quietly useful to a minority of buyers, and the third makes the label look fuller than it functionally is. The mechanisms are worked through on how it works.
Which Sciatica PRO+ ingredients reach the amount that was studied?
Printed amounts against trial amounts, arithmetic shown.
Because every figure is printed, every figure can be checked against the trials that made its ingredient interesting. Six rows have a comparison available; a daily requirement is a target rather than a trial dose, so the four vitamins do not.
| Ingredient | On this label | Closest researched amount | Share of it |
|---|---|---|---|
| Alpha lipoic acid | 400 mg | 600 mg a day | 67 per cent |
| Benfotiamine | 150 mg | 300 mg, the lower BENDIP arm | 50 per cent |
| Acetyl L-carnitine | 50 mg | 1,500 mg, the lower trial arm | 3 per cent |
| Ashwagandha | 25 mg of powder | 300 mg of standardised extract | A different unit, and a smaller number |
| Turmeric | 25 mg of powder, about 0.8 mg curcumin | 500 mg of curcumin | Under one part in six hundred |
| Broccoli powder | 25 mg of leaf | Sprout extract in the human work | No comparison at this form |
Percentages are arithmetic on the printed figure against the lowest trial amount named in the cards above.
The top line is the good news and it should be read first. Alpha lipoic acid has the strongest nerve literature on this panel and it is also the row given the largest amount. Two-thirds of a researched dose is not the researched dose, though it lands in the same bracket rather than being a gesture, and plenty of formulas in this category put their biggest number behind their cheapest ingredient instead.
Benfotiamine at half the lower trial arm is a shortfall rather than a rounding error, and BENDIP's result improved as the amount rose. Acetyl L-carnitine cannot be defended on quantity at all: three per cent of the smaller trial amount, in a study where only the larger amount moved pain scores.
The three powders are a different case again: not small versions of the trial material but a different preparation, with numbers that do not scale between the two.
What the Sciatica PRO+ ingredients have actually been tested on
Who was in these trials, and what transfers from them.
| Ingredient | Who was studied | What was measured | Fit with a compressed nerve |
|---|---|---|---|
| Alpha lipoic acid | Adults with diabetic polyneuropathy | Symptom and impairment scores, weeks to years | A metabolic nerve injury, not a mechanical one |
| Benfotiamine | Adults with diabetic polyneuropathy | Symptom scores over three to six weeks | Same population, same limitation |
| Acetyl L-carnitine | Adults with chronic diabetic neuropathy | Pain, fibre regeneration, vibration sense | Same again, at gram doses |
| Vitamin B12 | People with a confirmed deficiency | Reversal of deficiency-related damage | Relevant where a deficiency exists |
| Vitamin D3 | Adults with painful neuropathy, four small trials | Pain scores | Too little evidence either way |
| Ashwagandha | Adults under stress; one thyroid trial | Anxiety, sleep, thyroid hormones | Not a nerve endpoint |
| Broccoli and curcumin | Prediabetes; one nano-curcumin neuropathy trial | Fasting glucose; neuropathy severity | Other preparations entirely |
Populations as reported in the trials cited on this page.
One pattern runs through the right-hand column. Nearly all the nerve research behind these ingredients was carried out in diabetic polyneuropathy: damage caused by years of high blood glucose, diffuse, symmetrical and metabolic in origin.
Sciatica has a different cause. A disc or a narrowed canal presses on a single nerve root, and the trouble is mechanical from start to finish; the New England Journal review sets the distinction out clearly. Nutrients studied in a metabolic nerve injury have no established bearing on a compressed root, and none of these trials enrolled anyone with one. Who it is for follows that through.
What else is inside a Sciatica PRO+ capsule
Three lines under the panel, and what each of them is doing.
Beneath the panel the label prints three inactive ingredients: hypromellose (vegetable capsule), brown rice flour, magnesium stearate.
The shell is the first of those: a cellulose spun from plant fibre, used where a competitor would use gelatin, which is what makes these capsules workable on a vegetarian diet. Brown rice flour fills the space a 675 mg active load leaves in a capsule body, and magnesium stearate is a flow agent used in thousandths of a gram to keep powder off the filling machinery.
An allergen line follows: no added eggs, dairy, wheat or preservatives. Sugars, sweeteners, colourings and flavourings are absent from this format altogether, which is a capsule's quiet advantage over a chewable.
Why the Sciatica PRO+ ingredient list can be checked at all
The reason this page could be written at all.
Every row on this panel carries its own figure, which sounds unremarkable until you hold it against the rest of the shelf. A proprietary blend is the norm there: eight botanicals grouped under one total weight, so the eight could be split 700 mg to 1 mg and the label would look identical either way. What a blend removes is the reader's ability to do what this page has just done, which is take a number, find the trial and work out the ratio.
So the transparency cuts both ways. Printing the amounts is what lets this desk describe four of them as small. The supplement facts page reproduces the panel row by row, and testing and quality covers what a printed figure is evidence of.
Sciatica PRO+ ingredient questions
Which ingredient is present in the largest amount?
Alpha lipoic acid, at 400 mg per two-capsule serving. It accounts for more than half the weight of the active material and it is also the ingredient with the deepest nerve research behind it.
Is the alpha lipoic acid amount the one used in trials?
Not quite. The oral trial programme settled on 600 mg a day and this label supplies 400 mg, about two-thirds. No trial has tested 400 mg, though it is in the same region rather than a token amount.
Why is there only 50 mg of acetyl L-carnitine?
Nobody at this desk defends that row. The neuropathy trials ran at 1,500 and 3,000 mg daily, with the improvement in pain confined to the larger arm, and 50 mg is an amount no study has ever put to the test.
How much curcumin does the turmeric supply?
Roughly 0.8 mg. Culinary turmeric powder averages about 3 per cent curcuminoids, so 25 mg of powder yields under a milligram, against trial amounts measured in hundreds of milligrams of standardised extract.
Does any ingredient here treat sciatica?
No. The cause of sciatica is mechanical: a disc or a narrowed canal squeezing a nerve root. None of these ten is a painkiller and none reaches that cause. The label claims nutritional support for nerve health and nothing beyond it.
Who publishes this Sciatica PRO+ website?
- Ziegler D, Ametov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29(11):2365-70. PMID 17065669. https://pubmed.ncbi.nlm.nih.gov/17065669/
- Ziegler D, Hanefeld M, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). Diabetes Care. 1999;22(8):1296-301. PMID 10480774. https://pubmed.ncbi.nlm.nih.gov/10480774/
- Ziegler D, Low PA, et al. Predictors of improvement and progression of diabetic polyneuropathy following treatment with alpha-lipoic acid for 4 years in the NATHAN 1 trial. J Diabetes Complications. 2016;30(2):350-6. PMID 26651260. https://pubmed.ncbi.nlm.nih.gov/26651260/
- Hsieh RY, Huang IC, et al. Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review. Nutrients. 2023;15(16):3634. PMID 37630823. https://pubmed.ncbi.nlm.nih.gov/37630823/
- Stracke H, Gaus W, et al. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes. 2008;116(10):600-5. PMID 18473286. https://pubmed.ncbi.nlm.nih.gov/18473286/
- Haupt E, Ledermann H, et al. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther. 2005;43(2):71-7. PMID 15726875. https://pubmed.ncbi.nlm.nih.gov/15726875/
- Ciubotaru A, Grosu C, et al. Alpha-Lipoic Acid and Benfotiamine in Diabetic Peripheral Neuropathy: A Critical Review of Mechanistic Rationale and Clinical Evidence Within a Nutritional Therapeutic Framework. Nutrients. 2026;18(10). PMID 42196997. https://pubmed.ncbi.nlm.nih.gov/42196997/
- Sima AA, Calvani M, et al. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care. 2005;28(1):89-94. PMID 15616239. https://pubmed.ncbi.nlm.nih.gov/15616239/
- Li S, Li Q, et al. Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015;10(3):e0119479. PMID 25751285. https://pubmed.ncbi.nlm.nih.gov/25751285/
- Rolim LC, da Silva EM, et al. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2019;6(6):CD011265. PMID 31201734. https://pubmed.ncbi.nlm.nih.gov/31201734/
- Akhgarjand C, Asoudeh F, et al. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022;36(11):4115-4124. PMID 36017529. https://pubmed.ncbi.nlm.nih.gov/36017529/
- Chaurasiya ND, Uniyal GC, et al. Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection. Phytochem Anal. 2008;19(2):148-54. PMID 17879227. https://pubmed.ncbi.nlm.nih.gov/17879227/
- Sharma AK, Basu I, et al. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. J Altern Complement Med. 2018;24(3):243-248. PMID 28829155. https://pubmed.ncbi.nlm.nih.gov/28829155/
- Bjornsson HK, Bjornsson ES, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-829. PMID 31991029. https://pubmed.ncbi.nlm.nih.gov/31991029/
- Conaway CC, Getahun SM, et al. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr Cancer. 2000;38(2):168-78. PMID 11525594. https://pubmed.ncbi.nlm.nih.gov/11525594/
- Negi G, Kumar A, et al. Nrf2 and NF-kB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr Neurovasc Res. 2011;8(4):294-304. PMID 22023613. https://pubmed.ncbi.nlm.nih.gov/22023613/
- Dwibedi C, Axelsson AS, et al. Effect of broccoli sprout extract and baseline gut microbiota on fasting blood glucose in prediabetes: a randomized, placebo-controlled trial. Nat Microbiol. 2025;10(3):681-693. PMID 39929977. https://pubmed.ncbi.nlm.nih.gov/39929977/
- Tayyem RF, Heath DD, et al. Curcumin content of turmeric and curry powders. Nutr Cancer. 2006;55(2):126-31. PMID 17044766. https://pubmed.ncbi.nlm.nih.gov/17044766/
- Shoba G, Joy D, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4):353-6. PMID 9619120. https://pubmed.ncbi.nlm.nih.gov/9619120/
- Anand P, Kunnumakkara AB, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807-18. PMID 17999464. https://pubmed.ncbi.nlm.nih.gov/17999464/
- Asadi S, Gholami MS, et al. Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial. Complement Ther Med. 2019;43:253-260. PMID 30935539. https://pubmed.ncbi.nlm.nih.gov/30935539/
- MedlinePlus Medical Encyclopedia. Vitamin D. U.S. National Library of Medicine. https://medlineplus.gov/ency/article/002405.htm
- Yammine K, Abi Kharma J, et al. Is diabetic neuropathy associated with vitamin D status? A meta-analysis. Br J Nutr. 2022;127(7):972-981. PMID 34024290. https://pubmed.ncbi.nlm.nih.gov/34024290/
- Gilbody A, Gilbody J. Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Endocrinol Diabetes Metab. 2025;8(6):e70118. PMID 41139799. https://pubmed.ncbi.nlm.nih.gov/41139799/
- Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149-60. PMID 23301732. https://pubmed.ncbi.nlm.nih.gov/23301732/
- Hunt A, Harrington D, et al. Vitamin B12 deficiency. BMJ. 2014;349:g5226. PMID 25189324. https://pubmed.ncbi.nlm.nih.gov/25189324/
- Parsonage I, Wainwright D, et al. Vitamin B12 deficiency in long-term metformin use and clinician awareness: a scoping review. BMJ Open. 2026;16(4):e113829. PMID 42009383. https://pubmed.ncbi.nlm.nih.gov/42009383/
- MedlinePlus Medical Encyclopedia. Vitamin B12. U.S. National Library of Medicine. https://medlineplus.gov/ency/article/002403.htm
- Reynolds EH. What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies. Eur J Clin Nutr. 2016;70(5):537-40. PMID 26862004. https://pubmed.ncbi.nlm.nih.gov/26862004/
- MedlinePlus Medical Encyclopedia. Folic acid in diet. U.S. National Library of Medicine. https://medlineplus.gov/ency/article/002408.htm
- Miller JW, Smith A, et al. Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications? Food Nutr Bull. 2024;45(1_suppl):S67-S72. PMID 38987872. https://pubmed.ncbi.nlm.nih.gov/38987872/
- Schaumburg H, Kaplan J, et al. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med. 1983;309(8):445-8. PMID 6308447. https://pubmed.ncbi.nlm.nih.gov/6308447/
- Muhamad R, Akrivaki A, et al. The Role of Vitamin B6 in Peripheral Neuropathy: A Systematic Review. Nutrients. 2023;15(13):2823. PMID 37447150. https://pubmed.ncbi.nlm.nih.gov/37447150/
- Ropper AH, Zafonte RD. Sciatica. N Engl J Med. 2015;372(13):1240-8. PMID 25806916. https://pubmed.ncbi.nlm.nih.gov/25806916/
Order Sciatica PRO+ with the whole panel in front of you
Ten ingredients, ten printed amounts, and every comparison on this page drawn from the figures on the bottle. 60 days to change your mind.
Packs from $158 · six bottles for $294 · 60-day money-back guarantee
Order Sciatica PRO+ On The Official WebsiteTwo capsules a day · 60 per bottle · lot SCI-26/GE-2574